# Targeted Limbic Self-modulation as a Potential Treatment for Patients Suffering From Fibromyalgia

> **NCT02146495** · NA · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 70 (actual)

## Conditions studied

- Fibromyalgia (FM)

## Interventions

- **DEVICE:** Simultaneous EEG and fMRI recordings
- **DEVICE:** Amygdala-Electrical Fingerprint (Amyg-EFP)-NF Trial
- **DEVICE:** Amygdala-Electrical Fingerprint (Amyg-EFP)-NF Sham Trial

## Key facts

- **NCT ID:** NCT02146495
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02146495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02146495, "Targeted Limbic Self-modulation as a Potential Treatment for Patients Suffering From Fibromyalgia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02146495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*